Premium
NICE approval of adalimumab for moderate‐to‐severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
Author(s) -
Ingram J.R.,
Burton T.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15255
Subject(s) - adalimumab , hidradenitis suppurativa , medicine , nice , psoriasis , food and drug administration , psychological intervention , family medicine , dermatology , nursing , pharmacology , disease , computer science , programming language